Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Bibliographic Details
Main Authors: Bedognetti, Davide, Wang, Ena, Marincola, Francesco M
Format: Online
Language:English
Published: Landes Bioscience 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/

Similar Items